A vaccines is a biological preparation that helps to fight against any particular diseases and boost up the immunity. A vaccines contain an agent that similar to a disease causing organism and it is made from weakened or killed form of microbes. The vaccines can be prophylactic or therapeutic. According to the world health organization currently licensed vaccines are available to prevent around twenty five infections. The efficacy of the vaccine is depends on disease pathophysiology, the stain of the vaccine, the schedule of the vaccination, ethnicity, and genetic predisposition. As the globalization is increasing, the international traveling will also keep increasing. This create the demand for travel vaccines. The prevalence of infectious diseases are very specific in specific region. Moreover vaccines are widely used as a preventive measure against the known infectious diseases. The travelers are educated to follow the region-specific immunization plan.
Depend on the types of composition, the traveler’s vaccines are of two types, mono vaccines and combination vaccines. The combination vaccines are the fastest growing segment in traveler’s vaccines as compare to the mono vaccines as they reduces the number of injection required, indicated to treat multiple disease such as diphtheria, tetanus & pertussis, and increase immune compliance. Depends on the type of uses, the vaccines are of following types:
- Attenuated vaccines
- Inactive vaccines
- Subunit vaccines
- Toxoid vaccines
- Conjugate vaccines
- DNA Vaccines
- Recombinant vector vaccines
Extreme low risk of serious side effects on fetus and educational & awareness programs through the various government and nonprofit organization are factors that help to boosts the market. Growing preferences for outsourcing of vaccine in the developing and under developed countries open the path to boosts the traveler’s vaccines market. It is expected to grow because of the increase in outbound travel and increase in vaccination coverage due to its awareness. Whereas strict regulatory pathway and high cost associated with new vaccine discovery and development resist the market growth. Addition to it, high cost associate with vaccine transportation, storage, and handling also restrain the market growth.
Geographically, the U.S. is likely to dominate the human vaccines market in North America. The combination vaccines segment is anticipated to expand at a high base in North America, followed by the attenuated vaccines and recombinant vaccines segments. In terms of product, the meningococcal vaccines segment is poised to expand at a high rate. In Europe, increase in demand for vaccination and increase in research and development expenditure boost the traveler’s vaccines market. Asia Pacific is an emerging market for traveler’s vaccine market due to the developing healthcare infrastructure and rising government expenditures by conducting educational & awareness programs. In Middle East and African countries the development of the healthcare project and economy help to boost traveler’s vaccine market. However, affordability issues and poor patient education are factors restraining the market growth. The Government of Saudi Arabia runs routine vaccination programs for flu, influenza, and other vaccines in the country that create an opportunity in the traveler’s vaccine market.
Major Key players in the travel vaccine market include GlaxoSmithKline plc, Merck & Co., Inc, Pfizer Inc., and Sanofi S.A.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.